Action leveraging evidence to reduce perinatal mortality and morbidity (ALERT): study protocol for a stepped-wedge cluster-randomised trial in Benin, Malawi, Tanzania and Uganda.
Childbirth
Health system intervention
Hospital
Intrapartum care
Maternal health
Midwifery
Perinatal health
Respectful maternity care
Sub-Saharan Africa
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
11 Dec 2021
11 Dec 2021
Historique:
received:
24
09
2021
accepted:
11
10
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Insufficient reductions in maternal and neonatal deaths and stillbirths in the past decade are a deterrence to achieving the Sustainable Development Goal 3. The majority of deaths occur during the intrapartum and immediate postnatal period. Overcoming the knowledge-do-gap to ensure implementation of known evidence-based interventions during this period has the potential to avert at least 2.5 million deaths in mothers and their offspring annually. This paper describes a study protocol for implementing and evaluating a multi-faceted health care system intervention to strengthen the implementation of evidence-based interventions and responsive care during this crucial period. This is a cluster randomised stepped-wedge trial with a nested realist process evaluation across 16 hospitals in Benin, Malawi, Tanzania and Uganda. The ALERT intervention will include four main components: i) end-user participation through narratives of women, families and midwifery providers to ensure co-design of the intervention; ii) competency-based training; iii) quality improvement supported by data from a clinical perinatal e-registry and iv) empowerment and leadership mentoring of maternity unit leaders complemented by district based bi-annual coordination and accountability meetings. The trial's primary outcome is in-facility perinatal (stillbirths and early neonatal) mortality, in which we expect a 25% reduction. A perinatal e-registry will be implemented to monitor the trial. Our nested realist process evaluation will help to understand what works, for whom, and under which conditions. We will apply a gender lens to explore constraints to the provision of evidence-based care by health workers providing maternity services. An economic evaluation will assess the scalability and cost-effectiveness of ALERT intervention. There is evidence that each of the ALERT intervention components improves health providers' practices and has modest to moderate effects. We aim to test if the innovative packaging, including addressing specific health systems constraints in these settings, will have a synergistic effect and produce more considerable perinatal mortality reductions. Pan African Clinical Trial Registry ( www.pactr.org ): PACTR202006793783148. Registered on 17th June 2020.
Sections du résumé
BACKGROUND
BACKGROUND
Insufficient reductions in maternal and neonatal deaths and stillbirths in the past decade are a deterrence to achieving the Sustainable Development Goal 3. The majority of deaths occur during the intrapartum and immediate postnatal period. Overcoming the knowledge-do-gap to ensure implementation of known evidence-based interventions during this period has the potential to avert at least 2.5 million deaths in mothers and their offspring annually. This paper describes a study protocol for implementing and evaluating a multi-faceted health care system intervention to strengthen the implementation of evidence-based interventions and responsive care during this crucial period.
METHODS
METHODS
This is a cluster randomised stepped-wedge trial with a nested realist process evaluation across 16 hospitals in Benin, Malawi, Tanzania and Uganda. The ALERT intervention will include four main components: i) end-user participation through narratives of women, families and midwifery providers to ensure co-design of the intervention; ii) competency-based training; iii) quality improvement supported by data from a clinical perinatal e-registry and iv) empowerment and leadership mentoring of maternity unit leaders complemented by district based bi-annual coordination and accountability meetings. The trial's primary outcome is in-facility perinatal (stillbirths and early neonatal) mortality, in which we expect a 25% reduction. A perinatal e-registry will be implemented to monitor the trial. Our nested realist process evaluation will help to understand what works, for whom, and under which conditions. We will apply a gender lens to explore constraints to the provision of evidence-based care by health workers providing maternity services. An economic evaluation will assess the scalability and cost-effectiveness of ALERT intervention.
DISCUSSION
CONCLUSIONS
There is evidence that each of the ALERT intervention components improves health providers' practices and has modest to moderate effects. We aim to test if the innovative packaging, including addressing specific health systems constraints in these settings, will have a synergistic effect and produce more considerable perinatal mortality reductions.
TRIAL REGISTRATION
BACKGROUND
Pan African Clinical Trial Registry ( www.pactr.org ): PACTR202006793783148. Registered on 17th June 2020.
Identifiants
pubmed: 34895216
doi: 10.1186/s12913-021-07155-z
pii: 10.1186/s12913-021-07155-z
pmc: PMC8665312
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1324Subventions
Organisme : Horizon 2020
ID : 847824
Investigateurs
Gertrude Namazzi
(G)
Josephine Babirye
(J)
Philip Wanduru
(P)
Helle Mölsted Alvesson
(HM)
Nicola Orsini
(N)
Regine Unkels
(R)
Virginia Castellano Pleguezuelo
(VC)
Rian Snijders
(R)
Therese Delvaux
(T)
Bianca Kandeya
(B)
Razak Mussa
(R)
Samuel Meja
(S)
William Stones
(W)
Yesaya Z Nyirenda
(YZ)
Ahossi Angèle Florence Laure
(AAF)
Antoinette Sognonvi
(A)
Armelle Vigan
(A)
Banougnin Bolade Hamed
(BB)
Kéfilath Bello
(K)
Christelle Boyi Metogni
(CB)
Gisele Houngbo
(G)
Gottfried Agballa
(G)
Hashim Hounkpati
(H)
Schadrac Agbla
(S)
Joanne Welsh
(J)
Muzdalifat Abeid
(M)
Tumbwene Mwansisya
(T)
Fadhlun M Alwy Al-Beity
(FM)
Zamoyoni Julius
(Z)
Dickson Mkoka
(D)
Lilian T Mselle
(LT)
Beatrice Mwilike
(B)
Helga Naburi
(H)
Elizabeth O Ayebare
(EO)
Andrea B Pembe
(AB)
Ann-Beth Nygaard Moller
(AN)
Bruno Marchal
(B)
Claudia Hanson
(C)
Effie Chipeta
(E)
Elizabeth Ombeva Ayebare
(EO)
Hashim Hounkpatin
(H)
Pacos Gandaho
(P)
Hussein L Kidanto
(HL)
Jean-Paul Dossou
(JP)
Joseph Akuze
(J)
Kristi Sidney Annerstedt
(KS)
Lenka Benova
(L)
Lilian Mselle
(L)
Mechthild Gross
(M)
Peter Waiswa
(P)
Wim Van Damme
(W)
Jennifer Hall
(J)
Erik Lampa
(E)
Zahida Qureshi
(Z)
Informations de copyright
© 2021. The Author(s).
Références
Health Policy Plan. 2017 Oct 1;32(8):1146-1152
pubmed: 28541422
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
Trials. 2011 Jun 14;12:151
pubmed: 21672223
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Trials. 2017 Mar 4;18(1):101
pubmed: 28259174
Acta Obstet Gynecol Scand. 2010 Oct;89(10):1263-9
pubmed: 20846059
BMJ Glob Health. 2019 Mar 7;4(2):e001214
pubmed: 30997164
Value Health. 2013 Mar-Apr;16(2):e1-5
pubmed: 23538200
Qual Manag Health Care. 1998 Sep;6(4):1-13
pubmed: 10339040
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Environ Res. 2011 Apr;111(3):451-62
pubmed: 21333980
PLoS Med. 2019 Feb 19;16(2):e1002749
pubmed: 30779738
Health Policy Plan. 2018 Jan 1;33(1):e26-e33
pubmed: 29304252
BMJ Glob Health. 2017 Oct 31;2(4):e000486
pubmed: 29225953
BJOG. 2017 Mar;124(4):584-594
pubmed: 27704703
BJOG. 2015 Jul;122(8):1045-9
pubmed: 25929823
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308
pubmed: 30361107
J Epidemiol Community Health. 2018 Sep;72(9):776-782
pubmed: 29764902
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
Lancet. 2007 Oct 13;370(9595):1358-69
pubmed: 17933651
Int J Gynaecol Obstet. 2015 Oct;131(1):9-12
pubmed: 26433400
Lancet. 2016 Oct 29;388(10056):2176-2192
pubmed: 27642019
Lancet Glob Health. 2021 Jan;9(1):e24-e32
pubmed: 33275948
J Clin Epidemiol. 2016 Aug;76:229-37
pubmed: 26931284
Implement Sci. 2017 Jul 18;12(1):89
pubmed: 28720114
Lancet Glob Health. 2019 Mar;7(3):e347-e356
pubmed: 30784635
Cochrane Database Syst Rev. 2017 Nov 17;11:CD011558
pubmed: 29148566
PLoS Med. 2015 Jun 30;12(6):e1001847; discussion e1001847
pubmed: 26126110
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Biometrics. 2001 Dec;57(4):1198-206
pubmed: 11764261
J Clin Epidemiol. 2018 Nov;103:82-91
pubmed: 29885427
Health Policy Plan. 2019 Sep 1;34(7):544-552
pubmed: 31365066
Arch Dis Child. 2015 Jun;100(6):565-70
pubmed: 24819369
Lancet Glob Health. 2019 Jan;7(1):e96-e109
pubmed: 30554766
Int J Qual Health Care. 2020 Apr 21;32(1):54-63
pubmed: 31829427
Reprod Health. 2017 Sep 22;14(1):118
pubmed: 28938885
Trop Med Int Health. 2017 Jan;22(1):63-73
pubmed: 27910181
BMC Health Serv Res. 2014 Jun 20;14:275
pubmed: 24950878
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799
Afr J Reprod Health. 2006 Aug;10(2):72-80
pubmed: 17217119
Evaluation (Lond). 2019 Jan;25(1):23-45
pubmed: 30705608
Trials. 2015 Aug 17;16:350
pubmed: 26279013
Implement Sci. 2020 May 4;15(1):27
pubmed: 32366269
Lancet. 2007 Dec 22;370(9605):2158-63
pubmed: 17574662
Implement Sci. 2021 Jan 7;16(1):4
pubmed: 33413504
Int J Qual Health Care. 2005 Oct;17(5):447-54
pubmed: 15872024
Lancet Glob Health. 2020 Aug;8(8):e1061-e1070
pubmed: 32710862
N Engl J Med. 2017 Dec 14;377(24):2313-2324
pubmed: 29236628
BMJ. 2018 Jul 30;362:k2813
pubmed: 30061366